Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$61.5K Sell
607
-100
-14% -$11.4K ﹤0.01% 1100
2026
Q2
$83.6K Sell
707
-64
-8% -$7.39K ﹤0.01% 988
2026
Q1
$92.1K Buy
+771
New +$101K ﹤0.01% 910
2025
Q4
– Sell
-1,297
Closed -$191K – 1671
2025
Q3
$191K Buy
+1,297
New +$180K ﹤0.01% 631
2025
Q2
– Sell
-1,141
Closed -$136K – 1753
2025
Q1
$136K Sell
1,141
-68
-6% -$8.43K ﹤0.01% 687
2024
Q4
$140K Sell
1,209
-15
-1% -$1.9K ﹤0.01% 666
2024
Q3
$165K Sell
1,224
-17
-1% -$2.27K ﹤0.01% 626
2024
Q2
$160K Buy
1,241
+121
+11% +$16.5K ﹤0.01% 672
2024
Q1
$128K Buy
+1,120
New +$135K ﹤0.01% 638

Other funds holding XYL

Mather Group's XYL Position: Q3 2026 in Review

Mather Group reduced its Xylem (XYL) stake by 14% in Q3 2026, selling an estimated $11.4K and leaving 607 shares worth $61.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1100.

Mather Group first reported a position in XYL in Q1 2024 and has held it in 9 quarters since. The position peaked at $191K in Q3 2025. 204 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

  • Mather Group held 607 shares of Xylem worth $61.5K as of Q3 2026.
  • Mather Group sold 100 Xylem shares in Q3 2026, an estimated $11.4K.
  • Xylem made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1100 holding.
  • Mather Group first reported a position in Xylem in Q1 2024 and has held it in 9 quarters since.
  • Mather Group's Xylem position peaked at $191K in Q3 2025.
  • 204 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.